CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Alibaba
BABA
|
$2.59M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 4 |
Intel
INTC
|
$2.07M |
| 5 |
Coca-Cola
KO
|
$1.91M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
GraniteShares Gold Shares
BAR
$1.17B
| $703K | 0.09% |
32,000
+12,000
| +60% | +$264K |
|
|
152
Coca-Cola
KO
$297B
| $703K | 0.09% |
11,409
-31,003
| -73% | -$1.91M |
|
|
SWTX
153
DELISTED
SpringWorks Therapeutics
SWTX
| $699K | 0.09% |
14,194
+6,957
| +96% | +$342K |
|
154
XPeng
XPEV
$19.8B
| $691K | 0.09% |
90,000
+12,600
| +16% | +$96.8K |
|
155
ImmunityBio
IBRX
$2.25B
| $689K | 0.09% |
128,321
+51,086
| +66% | +$274K |
|
156
Fortrea Holdings
FTRE
$909M
| $686K | 0.09% |
17,097
+6,829
| +67% | +$274K |
|
157
Arrowhead Research
ARWR
$3.55B
| $682K | 0.09% |
23,838
+11,409
| +92% | +$326K |
|
158
Diageo
DEO
$61.5B
| $670K | 0.09% |
4,454
-2,480
| -36% | -$373K |
|
159
Amicus Therapeutics
FOLD
$2.43B
| $669K | 0.09% |
56,751
+22,831
| +67% | +$269K |
|
160
McDonald's
MCD
$225B
| $663K | 0.08% |
2,353
-1,791
| -43% | -$505K |
|
161
PayPal
PYPL
$66.2B
| $648K | 0.08% |
9,678
-9,323
| -49% | -$625K |
|
162
AbbVie
ABBV
$374B
| $646K | 0.08% |
+3,545
| New | +$646K |
|
163
Analog Devices
ADI
$122B
| $640K | 0.08% |
3,237
+1,246
| +63% | +$246K |
|
164
Deckers Outdoor
DECK
$18.2B
| $635K | 0.08% |
675
-999
| -60% | -$940K |
|
165
IDEAYA Biosciences
IDYA
$2.23B
| $630K | 0.08% |
14,347
+6,894
| +92% | +$303K |
|
166
Crinetics Pharmaceuticals
CRNX
$3.14B
| $626K | 0.08% |
13,364
+5,643
| +73% | +$264K |
|
167
Xenon Pharmaceuticals
XENE
$3.03B
| $625K | 0.08% |
14,520
+5,974
| +70% | +$257K |
|
168
Honeywell
HON
$138B
| $604K | 0.08% |
2,942
+1,630
| +124% | +$335K |
|
169
Walmart
WMT
$781B
| $590K | 0.08% |
9,647
-10,358
| -52% | -$633K |
|
170
Acadia Pharmaceuticals
ACAD
$4.33B
| $585K | 0.07% |
31,654
+12,669
| +67% | +$234K |
|
171
Airbnb
ABNB
$78.1B
| $576K | 0.07% |
3,494
+2,619
| +299% | +$432K |
|
172
Danaher
DHR
$146B
| $570K | 0.07% |
2,280
+1,409
| +162% | +$352K |
|
173
Chevron
CVX
$326B
| $566K | 0.07% |
+3,590
| New | +$566K |
|
174
Summit Therapeutics
SMMT
$17.7B
| $558K | 0.07% |
134,845
+53,774
| +66% | +$223K |
|
175
Denali Therapeutics
DNLI
$2.26B
| $548K | 0.07% |
26,721
+10,740
| +67% | +$220K |
|